|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMFA03100027
|
ent-12-iso-LGD2
|
(5R,9S)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100011
|
ent-12-iso-LGE2
|
(5R,9S)-7,8-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100022
|
ent-15-epi-15-iso-LGD2
|
(8R,12S)-9,10-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100006
|
ent-15-epi-15-iso-LGE2
|
(8R,12S)-10,11-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100023
|
ent-15-iso-LGD2
|
(8R,12S)-9,10-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100007
|
ent-15-iso-LGE2
|
(8R,12S)-10,11-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100034
|
ent-5-epi-5-iso-LGD2
|
(8R,12S)-9,10-seco-9,11-dioxo-5S-hydroxy-6E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100018
|
ent-5-epi-5-iso-LGE2
|
(8R,12S)-10,11-seco-9,11-dioxo-5S-hydroxy-6E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100035
|
ent-5-iso-LGD2
|
(8R,12S)-9,10-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100019
|
ent-5-iso-LGE2
|
(8R,12S)-10,11-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100030
|
ent-8-epi-8-iso-LGD2
|
(11R,15S)-12,13-seco-12,14-dioxo-8S-hydroxy-5Z,9E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100014
|
ent-8-epi-8-iso-LGE2
|
(11R,15S)-13,14-seco-12,14-dioxo-8S-hydroxy-5Z,9E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100031
|
ent-8-iso-LGD2
|
(11R,15S)-12,13-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100015
|
ent-8-iso-LGE2
|
(11R,15S)-13,14-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100003
|
isoLGD2
|
9,10-seco-9,11-dioxo-15-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100004
|
isoLGE2
|
10,11-seco-9,11-dioxo-15-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100002
|
LGD2
|
(8R,12R)-9,10-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100001
|
LGE2
|
(8R,12R)-10,11-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03110221
|
11-epi-8-D2c-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,2S,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110222
|
11-epi-8-D2t-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,2R,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110212
|
11-epi-8-E2c-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,2S,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110211
|
11-epi-8-E2t-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110079
|
12-D2c-IsoP
|
6S,12S-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5R,9S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110085
|
12-D2t-IsoP
|
6S,12S-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5S,9R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110189
|
12-E2c-IsoP
|
4-((1R,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110190
|
12-E2t-IsoP
|
4-((1S,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110080
|
12-epi-12-D2c-IsoP
|
6S,12R-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5R,9S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110084
|
12-epi-12-D2t-IsoP
|
6S,12R-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5S,9R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110187
|
12-epi-12-E2c-IsoP
|
4-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110188
|
12-epi-12-E2t-IsoP
|
4-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110093
|
15-D2c-IsoP
|
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110099
|
15-D2t-IsoP
|
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110126
|
15-E2c-IsoP
|
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110094
|
15-epi-15-D2c-IsoP
|
9S,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110098
|
15-epi-15-D2t-IsoP
|
9S,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110124
|
15-epi-15-E2c-IsoP
|
9-oxo-11R,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110125
|
15-epi-15-E2t-IsoP
|
9-oxo-11R,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110239
|
5,12-diepi-12-D2c-IsoP
|
4-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110240
|
5,12-diepi-12-D2t-IsoP
|
4-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110191
|
5,12-diepi-12-E2c-IsoP
|
4-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110192
|
5,12-diepi-12-E2t-IsoP
|
4-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110231
|
5,8-diepi-5-D2c-IsoP
|
(R,E)-5-hydroxy-7-((1S,2S,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110232
|
5,8-diepi-5-D2t-IsoP
|
(R,E)-5-hydroxy-7-((1R,2R,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110065
|
5-D2c-IsoP
|
5S,9S-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110070
|
5-D2t-IsoP
|
5S,9S-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110173
|
5-E2c-IsoP
|
(S,E)-5-hydroxy-7-((1R,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110174
|
5-E2t-IsoP
|
(S,E)-5-hydroxy-7-((1S,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110237
|
5-epi-12-D2c-IsoP
|
4-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110238
|
5-epi-12-D2t-IsoP
|
4-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
|
LMFA03110193
|
5-epi-12-E2c-IsoP
|
4-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|